Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Potential therapeutic applications of phosphodiesterase inhibition in prostate cancer

Published:2012-03-02 Issue:2 Volume:31 Page:325-330
ISSN:0724-4983
Container-title:World Journal of Urology
language:en
Short-container-title:World J Urol

Author:

Hamilton Thomas K.,Hu Nianping,Kolomitro Klodiana,Bell Erin N.,Maurice Donald H.,Graham Charles H.,Siemens D. Robert

Publisher

Springer Science and Business Media LLC

Subject

Urology

Link

http://link.springer.com/content/pdf/10.1007/s00345-012-0848-7.pdf

Reference28 articles.

1. Semenza GL (2002) HIF-1 and tumor progression: pathophysiology and therapeutics. Trends Mol Med 8(4 suppl):S62–S67

2. Movsas B, Chapman JD, Greenberg RE et al (2000) Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: and Eppendorf pO(2) study. Cancer 89:2018–2024

3. Gillet J-P, Gottesmon MM (2010) Multi-drug resistance in cancer. Methods Mol Biol 596:47–76

4. Frederiksen LJ, Siemens DR, Heaton JP et al (2003) Hypoxia induced resistance to doxorubicin in prostate cancer cells is inhibited by low concentrations of glyceryl trinitrate. J Urol 170:1003–1007

5. Matthews NE, Adams MA, Maxwell LR et al (2001) Nitric oxide-mediated regulation of chemosensitivity in cancer cells. J Natl Cancer Inst 93:1879–1885

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PDE5 inhibitors against cancer via mediating immune cells in tumor microenvironment: AI‐based approach for future drug repurposing exploration;Interdisciplinary Medicine;2024-03-16

2. Advances in targeting Phosphodiesterase 1: From mechanisms to potential therapeutics;European Journal of Medicinal Chemistry;2024-01

3. Evaluation of a spray-dried amorphous solid dispersion formulation of ID11916, a new molecular entity with dual inhibition mechanisms targeting the androgen receptor and phosphodiesterase type-5;Journal of Pharmaceutical Investigation;2023-12-28

4. Identifying Phosphodiesterase‐5 Inhibitors with Drug Repurposing Approach: Implications in Vasodysfunctional Disorders;ChemistryOpen;2023-12-07

5. Incidence and risk factors of prostate cancer among the Northern and Eastern parts of the United Arab Emirates population;The Prostate;2023-11-15

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3